Literature DB >> 19348991

Management of facial bite wounds.

Panagiotis K Stefanopoulos1.   

Abstract

Bite wounds are especially prone to infectious complications, both local and systemic. In bite wounds to the face, such complications can create more difficulties than the initial tissue damage itself for the task of restoring an esthetic appearance. Management should aim to neutralize this potential for infection and provide an infection-free environment for wound healing. Wound cleansing followed by primary closure is the treatment of choice, and the use of prophylactic antibiotics may further decrease the risk of infection. Delay in presentation beyond 24 hours is not necessarily a contraindication to immediate repair, but excessive crushing of the tissues or extensive edema usually dictates a more conservative approach, such as delayed closure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19348991     DOI: 10.1016/j.coms.2008.12.009

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN: 1042-3699            Impact factor:   2.802


  5 in total

1.  Periorbital Trauma: A New Classification.

Authors:  Eman Yahya Sadek; Amir Elbarbary; Ikram I Safe
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2019-01-30

Review 2.  Animal and Human Bite Wounds.

Authors:  Karin Rothe; Michael Tsokos; Werner Handrick
Journal:  Dtsch Arztebl Int       Date:  2015-06-19       Impact factor: 5.594

3.  Prevention of post-operative infections after surgical treatment of bite wounds.

Authors:  Axel Kramer; Ojan Assadian; Matthias Frank; Claudia Bender; Peter Hinz
Journal:  GMS Krankenhhyg Interdiszip       Date:  2010-09-21

4.  Bear maul injuries in maxillofacial region: our experience.

Authors:  N T Geetha; H R Shivakumar; P Upasi Amarnath; Bekal Pattathan Rajesh Kumar; Rai Kirthikumar
Journal:  J Maxillofac Oral Surg       Date:  2011-12-25

5.  Management of human and animal bite wound infection: an overview.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.